Off-label use of recombinant factor VIIa

Comment

Anne Phillips. Ann Intern Med. 2011.

. 2011 Sep 6;155(5):337; author reply 338-9.

doi: 10.7326/0003-4819-155-5-201109060-00020.

No abstract available

Comment on

Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records.
Logan AC, Yank V, Stafford RS. Logan AC, et al. Ann Intern Med. 2011 Apr 19;154(8):516-22. doi: 10.7326/0003-4819-154-8-201104190-00002. Ann Intern Med. 2011. PMID: 21502649 Free PMC article.
Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications.
Yank V, Tuohy CV, Logan AC, Bravata DM, Staudenmayer K, Eisenhut R, Sundaram V, McMahon D, Olkin I, McDonald KM, Owens DK, Stafford RS. Yank V, et al. Ann Intern Med. 2011 Apr 19;154(8):529-40. doi: 10.7326/0003-4819-154-8-201104190-00004. Ann Intern Med. 2011. PMID: 21502651 Free PMC article.